The University of Saskatchewan's VIDO-InterVac has contracted two Canadian pharmaceutical companies to manufacture ingredients for its potential COVID-19 vaccine to be used in the first stages of human clinical trials. Toronto-based Dalton Pharma Services announced in a news release Tuesday it will be making parts of the vaccine being developed by the Vaccine and…